Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
B Sohrabi, B Dayeri, E Zahedi, S Khoshbakht… - Cancer Gene …, 2022 - nature.com
Mesenchymal stem cells (MSCs) are known as promising sources for cancer therapy and
can be utilized as vehicles in cancer gene therapy. MSC-derived exosomes are central …
can be utilized as vehicles in cancer gene therapy. MSC-derived exosomes are central …
MiRNA-related metastasis in oral cancer: moving and shaking
M Eslami, S Khazeni, XM Khanaghah, MH Asadi… - Cancer cell …, 2023 - Springer
Across the world, oral cancer is a prevalent tumor. Over the years, both its mortality and
incidence have grown. Oral cancer metastasis is a complex process involving cell invasion …
incidence have grown. Oral cancer metastasis is a complex process involving cell invasion …
Long noncoding RNA RC3H2 facilitates cell proliferation and invasion by targeting MicroRNA-101-3p/EZH2 axis in OSCC
K Wu, Y Jiang, W Zhou, B Zhang, Y Li, F Xie… - … Therapy-Nucleic Acids, 2020 - cell.com
In our previous studies, enhancer of zeste homolog 2 (EZH2) has been proven to be a key
oncogenic driver in oral squamous cell carcinoma (OSCC). However, the regulatory …
oncogenic driver in oral squamous cell carcinoma (OSCC). However, the regulatory …
[HTML][HTML] MiR-101: a potential therapeutic target of cancers
CZ Wang, F Deng, H Li, DD Wang… - American Journal of …, 2018 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are small noncoding RNAs that could regulate gene expressions
transcriptionally or post-transcriptionally through binding to 3'untranslated region (3'UTR) of …
transcriptionally or post-transcriptionally through binding to 3'untranslated region (3'UTR) of …
Advances in CXCR7 modulators
N Lounsbury - Pharmaceuticals, 2020 - mdpi.com
CXC chemokine receptor 7 (CXCR7) is a G-protein-coupled receptor that signals through
the β-arrestin pathway. Its ligands include interferon-inducible T cell α chemoattractant …
the β-arrestin pathway. Its ligands include interferon-inducible T cell α chemoattractant …
A looking-glass of non-coding RNAs in oral cancer
AI Irimie, C Braicu, L Sonea, AA Zimta… - International journal of …, 2017 - mdpi.com
Oral cancer is a multifactorial pathology and is characterized by the lack of efficient treatment
and accurate diagnostic tools. This is mainly due the late diagnosis; therefore, reliable …
and accurate diagnostic tools. This is mainly due the late diagnosis; therefore, reliable …
miR-101-5p acts as a tumor suppressor in HER2-positive breast cancer cells and improves targeted therapy
Purpose Human epidermal growth factor receptor 2 positive (HER2+) breast cancers
responding poorly to targeted therapy need improved treatment options. miR-101-5p has …
responding poorly to targeted therapy need improved treatment options. miR-101-5p has …
TNF-α inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis
Z Zheng, X Luan, J Zha, Z Li, L Wu, Y Yan, H Wang… - Cellular signalling, 2017 - Elsevier
Whereas TNF-α can facilitate the metastasis of oral squamous cancer cells (OSCC), whether
it inhibits the metastasis is not clear so far. In this study, we demonstrated that high dose TNF …
it inhibits the metastasis is not clear so far. In this study, we demonstrated that high dose TNF …
Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma
F Huang, C Xin, K Lei, H Bai, J Li, Q Chen - Cellular Oncology, 2020 - Springer
Background Oral squamous cell carcinoma (OSCC) has the highest mortality rate among all
head and neck cancers and a relatively low five-year survival rate. Generally, the …
head and neck cancers and a relatively low five-year survival rate. Generally, the …
The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology
Swati, V Sharma - Molecular Biology Reports, 2022 - Springer
Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer-related
death worldwide. Despite aggressive treatment approaches, the recurrence of HNSCC …
death worldwide. Despite aggressive treatment approaches, the recurrence of HNSCC …